Shahed Tish

Dr. Shahed Tish

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
STShahed Tish
Shahed Tish
RCRicard Corcelles
Ricard Corcelles
Sleeve gastrectomy (SG) has historically evolved from gastroplasty and anti-reflux procedures into one of the most commonly performed primary metabolic surgeries in the United States and worldwide. Initially initiated in the 1980s as part of the duodenal switch procedure, its standalone effectiveness and simplicity have led to increasing popularity globally. The rise in obesity rates transcends age boundaries, alarmingly affecting not only adults but also the younger demographic. This escalating trend is concerning, as it predisposes these populations to numerous future health complications, as well as highlighting the critical necessity for a safe and potent weight loss strategy. Although sleeve gastrectomy carries a higher risk for gastroesophageal reflux disease (GERD) compared to other bariatric procedures, it stands out as a reliable, safe and effective surgical solution for obesity. It is particularly beneficial for adolescents and patients with complex medical comorbidities, including, but not limited to, heart failure and immunocompromisation. It has also served as a bridge for transplants in morbidly obese patients with end-stage heart, liver and kidney disease due to its favorable safety profile.

1 April 2020 in Surgery
Verified
Journal Article
Closed access
RARaha AlMarzooqi
Raha AlMarzooqi
CPClayton Petro
Clayton Petro
STShahed Tish
Shahed Tish
AFAldo Fafaj
Aldo Fafaj
HAHemasat Alkhatib
Hemasat Alkhatib
MRMichael Rosen
Michael Rosen

20 January 2020 in Hernia
Verified
Journal Article
Closed access
PDF file
STShahed Tish
Shahed Tish
DKD. Krpata
D. Krpata
RAR. AlMarzooqi
R. AlMarzooqi
LHL.-C. Huang
L.-C. Huang
SPS. Phillips
S. Phillips
APA. Prabhu
A. Prabhu

6 February 2019 in Journal of Neurological Surgery Part B: Skull Base
Verified
Conference Paper
Closed access
SCSamantha Colby
Samantha Colby
JJJaes Jones
Jaes Jones
GHGhaith Habboub
Ghaith Habboub
AWAlex Witek
Alex Witek
STShahed Tish
Shahed Tish
PRPablo F. Recinos
Pablo F. Recinos
Introduction: Esthesioneuroblastoma, also referred to as olfactory neuroblastoma, is a rare malignant neoplasm arising from olfactory neuroepithelium. Aiming to provide a comprehensive epidemiologic analysis of esthesioneuroblastomas, this study draws from the Central Brain Tumor Registry of the United States (CBTRUS), which contains population-based incidence data covering 99% of the United States population from 1994 to 2014. Methods: CBTRUS was queried for esthesioneuroblastomas based on ICD-O-3 codes. Age-adjusted incidence per 100,000 persons was calculated and stratified by race, sex, age, lesion location, and diagnostic method. Joinpoint Regression Program was used to calculate annual percentage change in incidence rates over time. Results: A total of 2,103 esthesioneuroblastomas were diagnosed in the United States from 2001 to 2014, averaging ∼150 cases annually. The most common location was the nasal cavity (1709 cases). Those not located in the nasal cavity were found in the ethmoid (182 cases), sphenoid (50 cases), maxillary (39 cases), or accessory sinuses (68 cases). Overall age-adjusted rate was 0.0477 per 100,000 (95% CI, 0.0457–0.0498). There was no statistically significant change in annual rates from 2001 to 2014. A peak rate of 0.1331 per 100,000 (95% CI, 0.1118–0.1571) occurred in patients aged 75–79 years. The rate in males (0.0587 per 100,000; 95% CI, 0.0555–0.0622) was significantly higher (p < 0.05) than in females (0.0013 per 100,000; 95% CI, 0.0354–0.0406). The rate was highest in non-Hispanic white patients at 0.0495 per 100,000 (95% CI, 0.0472–0.0519). The rate ratio of esthesioneuroblastoma in black patients to non-Hispanic white patients was 0.6452 (p < 0.05). There were not enough American Indian/Alaska Native patients to form definitive conclusions. Conclusion: The incidence of esthesioneuroblastomas was higher in males relative to females, and in non-Hispanic white patients relative to black patients. Incidence peaked in patients aged 75 to 79 years. This study represents the most comprehensive epidemiological analysis of esthesioneuroblastoma incidence rate in the United States to date.

2 February 2018 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Open access
JVJosephine Volovetz
Josephine Volovetz
Min LangMin Lang
Min Lang
LDLu Dai
Lu Dai
GHGhaith Habboub
Ghaith Habboub
PDParamita Das
Paramita Das
PRPablo F. Recinos
Pablo F. Recinos
Background Pituitary adenomas are among the most common tumors of the central nervous system. Surgical resection is the first-line treatment option for symptomatic pituitary adenomas and for non-prolactinoma functional tumors. Resections are performed at both teaching and nonteaching hospitals across the country. Given differences between the hospitals, with medical education playing a role in teaching hospitals, there is a question of whether or not there is a difference in quality of care for pituitary adenoma resection patients. Outcomes after pituitary adenoma resection between the two types of hospitals have not previously been studied. Methods A retrospective study was performed of the Nationwide Inpatient Sample, a database of hospital admissions from more than 1,000 hospitals, between the years 2006 and 2011. Teaching and nonteaching hospital admissions for elective pituitary adenoma resection in patients ≥18 years old were included for analysis. Teaching hospitals are defined as those with an AMA-approved residency training program, those with membership in the Council of Teaching Hospitals, or those with a ratio of full-time interns and residents to beds of 1:4 or higher. Analysis between the two types of hospitals included a comparison of patient characteristics, including likelihood of dying and illness severity. The primary outcome explored was inpatient mortality, and the secondary outcome was length of stay. Results A total of 7,826 admissions from teaching hospitals and 1,618 admissions from nonteaching hospitals were compared. The median age and the proportion of females between the two patient populations had a statistically but not clinically significant difference. The illness severity and likelihood of dying of the patients in teaching hospitals compared with nonteaching hospitals were significantly different (p = 0.004 and p = 0.005, respectively), with more patients in nonteaching hospitals having an “extreme” severity of illness ranking and an “extreme” likelihood of dying ranking. In terms of comorbidities potentially associated with the pituitary adenoma, there were significantly more patients with hypothyroidism in teaching hospitals than in nonteaching hospitals (p = 0.028). No significant difference was seen in hospital deaths between the two groups, while a statistically but not clinically significant difference in length of stay was seen between the two (p < 0.001). Conclusion No significant difference in inpatient mortality after pituitary adenoma resection was found between teaching and nonteaching hospitals, although there may be a difference between the level of comorbidities of patients undergoing resection in teaching and nonteaching hospitals.